S. 4037
119th Congress
Senate
Diabetes Act
Official title: A bill to ensure continued access to diabetes technology upon Medicare enrollment, and for other purposes.
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2026
Read twice and referred to the Committee on Finance.
Mar 10, 2026
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Read twice and referred to the Committee on Finance.
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
24
- WILLIAMS AND JENSEN, PLLC
- VENABLE LLP
- BROWN & FORTUNATO, P.C.
- AMERICAN DIABETES ASSOCIATION
- NVG, LLC
- THE NICKLES GROUP, LLC
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Office of Management & Budget (OMB)
- Health & Human Services, Dept of (HHS)
- Executive Office of the President (EOP)
- Food & Drug Administration (FDA)
- Government Accountability Office (GAO)
Cosponsors
1
Cite this page
U.S. Congress. (2026). S. 4037: Diabetes Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-4037/
"S. 4037: Diabetes Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-4037/.
S. 4037, 119th Cong. (2026), https://openamerica.io/bill/119-S-4037/.
[S. 4037: Diabetes Act](https://openamerica.io/bill/119-S-4037/)